Online Course

2018 CARE MOC Session 1 - Vasculitis

Date:

Expires Sep 30, 2019

Program Information

CME: 4     MOC: 4

Assess your rheumatology medical knowledge and enhance your patient care. With 2018 CARE MOC Session 1 - Vasculitis you receive:

  • 12 case-based, multiple-choice questions with in-depth answer rationales
  • 4 AMA PRA Category 1 Credits™ and 4 ABIM MOC points with a passing score of 70% or higher

This online activity is for 2018 ACR/ARP Annual Meeting attendees only.

Target Audience
This course is designed for rheumatologists, physicians, and healthcare providers who care for patients with rheumatic diseases; and those interested or engaged in rheumatology research.

Learning Objectives
Upon completion of this program, participants should be able to:

  • Identify less commonly recognized clinical manifestations and disease outcomes
  • Explain the role of diagnostic testing in diagnosing disease and determining disease activity
  • Evaluate treatments used in different vasculitic syndromes and potential complications of therapy
  • Distinguish between systemic vasculitic diseases and their mimickers

Registration Fees

Free for 2018 ACR/ARP Annual Meeting attendees.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this online activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement
Successful completion of this CME activity enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Claim MOC Points
See instructions on how to claim MOC points

Faculty and Disclosures

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures.

  • Moderator: Allan C. Gelber, MD, PhD, MPH - No relevant financial relationships to disclose
  • Speaker: Sharon Chung, MD - No relevant financial relationships to disclose
  • Question Author: Vaneet Sandhu, MD - No relevant financial relationships to disclose
  • Question Author: Eveline Wu, MD - No relevant financial relationships to disclose

Additional Program Information

2018 Annual Meeting Live Session: October 21, 12:30 PM - 2:00 PM
Moderator: Allan C. Gelber, MD, PhD, MPH - Johns Hopkins University
Speaker: Sharon Chung, MD - University of California San Francisco
Question Authors: Vaneet Sandhu, MD - Loma Linda University and Eveline Wu, MD - University of North Carolina

About the Speaker
Dr. Chung completed her MD (2001) at Johns Hopkins University where she was also an intern and resident in Internal Medicine (2001 - 2004). She was a Rheumatology Clinical Fellow at UCSF (2004 - 2007) and joined the UCSF faculty in 2007. Dr. Chung completed a Master’s Degree in Advanced Studies in Clinical Research at UCSF (2008).

The central goal of Dr. Chung's research program is to discover genetic and epigenetic factors that influence autoimmune disease susceptibility and its manifestations, in order to identify biologic pathways involved in disease pathogenesis and potential targets for therapeutic intervention. Current projects focused on systemic lupus erythematosus (SLE) include genome-wide association studies, more focused investigations of the major histocompatilibity complex, and DNA methylation studies of specific disease manifestations. Her clinical interest is systemic vasculitis, and she directs the UCSF Vasculitis Clinic. Her research activities in vasculitis include genetic, epigenetic, and transcriptional studies of small vessel vasculitides. The UCSF Vasculitis Clinic is a member of the Vasculitis Clinical Research Consortium (VCRC), and the clinic participates in ongoing VCRC studies.

Contact Info / Inquiries

education@rheumatology.org
404-633-3777, ext. 381